Application Notes & Case Studies

  1. Market Approval For A Novel Non-Hodgkin Lymphoma (NHL) Therapy 4/11/2025

    Explore a collaboration that underscores the importance of strategic planning and regulatory engagement in the approval process.

  2. Post-Market Safety And Risk Management in DMD 4/11/2025

    The pharmaceutical company specializing in rare neurological diseases sought solutions after encountering significant hurdles in post-market safety surveillance.

  3. Setting A New Client Standard In Study Closeout Timelines 4/4/2025

    Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.

  4. 6 Key Ways Real-World Data Is Advancing Colorectal Cancer Therapies 4/3/2025

    Real-world data (RWD) is transforming Colorectal cancer (CRC) research by complementing traditional clinical trials, accelerating drug development, and improving patient outcomes.

  5. Timely Lab Data To Inform Outreach To Healthcare Professionals 4/3/2025

    Learn how you can leverage a system that offers flexible data delivery formats and seamless integration into commercialization workflows while also ensuring HIPAA-compliant deidentified data for patient privacy.

  6. Driving Early-Phase Success In Advanced Solid Tumors Study 3/24/2025

    ​A European biotech company collaborated with TFS HealthScience to conduct an early-phase clinical trial focusing on advanced and metastatic solid tumors.

  7. Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies 3/24/2025

    To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.

  8. Helping To Power The WHO Solidarity Trial Against COVID-19 3/21/2025

    To overcome the unprecedented challenges of large-scale global clinical trials, adopting data capture solutions is essential for ensuring the success of critical research initiatives.

  9. Streamlining Phase I/II Oncology Trials: A Global CRO Partnership 3/17/2025

    Through strategic planning, adaptive trial execution, and proactive collaboration, TFS successfully navigated the complexities of this early-phase oncology study.

  10. Tailored Solutions For A Global Phase III Neovascular AMD Study 3/17/2025

    How did a Phase III combination study for neovascular age-related macular degeneration (AMD) overcome study complexities while expanding across 16 countries?